Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
oleh: Ran D. Balicer, Michael Huerta, Nadav Davidovitch, Itamar Grotto
Format: | Article |
---|---|
Diterbitkan: | Centers for Disease Control and Prevention 2005-08-01 |
Deskripsi
We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.